Our results showed the TSEN54 expression was clearly upper in the TP53-Mutant group versus the TP53-NonMutant group, suggesting TP53 mutations possibly upregulate the expression level of TSEN54 and thus be involved in the development of HCC. The gene discussed is TP53; the disease is hepatocellular carcinoma.